TD Cowen analyst Stacy Ku maintained a Buy rating on scPharmaceuticals (SCPH – Research Report) yesterday and set a price target of ...

NYHA Class IV Approval: In August 2024, scPharmaceuticals announced that the U.S. Food and Drug Administration (FDA) granted approval for FUROSCIX, expanding the indication to include New York Heart ...

Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to announce that University of Iowa Health Care Stead Family ...

scPharmaceuticals Inc. ( NASDAQ: SCPH) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Nick Colangelo - Investor Relations John Tucker - Chief Executive Officer Steve Parsons - Senior ...

Nuwellis, Inc. (Nasdaq: NUWE), a medical device company focused on transforming the lives of people with fluid overload, today reported financial results ...

Reimbursement rate to increase 397% per day effective January 1, 2025New rate expected to encourage adoption of ultrafiltration therapy in the ...

A new way of treating heart failure patients at Mercy Hospital Washington has been a major success, according to the doctor ...

SeeMedX Inc. ("SeeMedX") today announced the submission of its 510(k) premarket notification to the U.S. Food and Drug ...

Nuwellis ( NASDAQ:NUWE ), this Minneapolis-based medical device company saw its shares rise by 121.32% today as the US ...

Doctors often recommend that heart patients monitor their fluid intake to avoid overhydration. The key is to strike a balance between staying hydrated and preventing fluid overload. Dehydration can ...

has adopted the Aquadex SmartFlow® system to treat pediatric patients suffering from fluid overload due to heart and kidney disease. The Stead Family Children’s Hospital will use the Aquadex ...